NasdaqCM - Delayed Quote USD
Jaguar Health, Inc. (JAGX)
At close: November 4 at 4:00 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -2.37 | -1.67 | -0.78 | -2.61 |
| Low Estimate | -2.37 | -1.67 | -0.78 | -2.61 |
| High Estimate | -2.37 | -1.67 | -0.78 | -2.61 |
| Year Ago EPS | -41.4 | -33 | -- | -0.78 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 3.94M | 3.65M | 12.66M | 18.19M |
| Low Estimate | 3.94M | 3.65M | 12.66M | 18.19M |
| High Estimate | 3.94M | 3.65M | 12.66M | 18.19M |
| Year Ago Sales | -- | 2.3M | 9.76M | 12.66M |
| Sales Growth (year/est) | -- | 58.70% | 29.70% | 43.70% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -91.8 | -73.8 | -1.8 | -1.2 |
| EPS Actual | -41.4 | -33 | -3.6 | -4.04 |
| Difference | 50.4 | 40.8 | -1.8 | -2.84 |
| Surprise % | 54.90% | 55.30% | -100.00% | -236.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -2.37 | -1.67 | -0.78 | -2.61 |
| 7 Days Ago | -2.37 | -1.67 | -0.78 | -2.61 |
| 30 Days Ago | -2.37 | -1.67 | -0.78 | -2.61 |
| 60 Days Ago | -2.37 | -1.67 | -0.78 | -2.61 |
| 90 Days Ago | -1.11 | -0.97 | -0.69 | -2.51 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | JAGX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 94.30% | -- | -- | 5.20% |
| Next Qtr. | 94.90% | -- | -- | 11.60% |
| Current Year | -- | -- | -- | 2.10% |
| Next Year | -234.60% | -- | -- | 12.30% |
| Next 5 Years (per annum) | 40.00% | -- | -- | 11.04% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
TNXP Tonix Pharmaceuticals Holding Corp.
0.1418
+1.79%
IBIO iBio, Inc.
2.6700
0.00%
VRPX Virpax Pharmaceuticals, Inc.
0.7100
-2.32%
PALI Palisade Bio, Inc.
2.7800
+0.72%
OCGN Ocugen, Inc.
0.9575
+0.86%
RNAZ TransCode Therapeutics, Inc.
0.5150
+7.29%
CNSP CNS Pharmaceuticals, Inc.
0.1071
-4.88%
ADTX Aditxt, Inc.
0.4900
-7.53%
APVO Aptevo Therapeutics Inc.
0.2820
+13.71%
CDIO Cardio Diagnostics Holdings, Inc.
0.2789
+7.27%